Business news – Page 34
-
OpinionDivergent reality
If the UK leaves the EU without a deal, the two will inevitably drift further apart
-
BusinessWhat might Brexit mean for industry?
Questions hang over regulation, trade, talent and investment
-
-
BusinessUS government sued for delaying dichloromethane paint stripper ban
Environmental Protection Agency advances long-awaited ban on consumer products, but allows commercial use to continue
-
OpinionIn search of ultimate selectivity
A catalyst that reacts only with aryl iodides, spurning bromides and chlorides
-
NewsBig costs, no benefits to UK’s replacement for EU chemical regulation
Industry warns small volume chemicals could no longer be sold in the UK
-
BusinessUK government sets out antimicrobial resistance plan
Aims to cut antibiotic use and explore financial incentives for pharmaceutical companies
-
OpinionThinking differently about waste
Plastic and carbon emissions are valuable resources we can’t afford to discard
-
BusinessBattling the US opioid epidemic
Adapt pharma’s naloxone nasal spray makes treating overdoses easier
-
ArticlePittcon 2019: the visible difference in laboratory science expositions
The Pennsylvania Convention Center in Philadelphia, Pennsylvania welcomes the 70th annual Pittcon.
-
ResearchPatent-busting AI tool navigates around protected drug pathways
Organic retrosynthesis software can identify key bonds involved in patented reactions to find alternative pathways
-
BusinessAntifouling coatings cling to copper
Copper coatings keep ships clear from unwanted sea life but environmental concerns mean some are keen to move away from the metal. Can it be replaced?
-
OpinionWhat are the rate-limiting steps in drug discovery?
Getting more drugs to market is not just a chemistry problem
-
BusinessPfizer to close two manufacturing plants in India
Closures will lead to the loss of 1700 jobs – almost 6% of the pharma giant’s manufacturing workforce
-
BusinessChinese plant closures disrupt supply chains
Environmental clampdown knocks out major suppliers of some ingredients
-
BusinessBristol-Myers Squibb to buy Celgene for $74 billion
Deal boosts BMS’s cancer and immunology pipeline with 5 drugs in late stage clinical trials
-
CareersRethinking industrial placements
How SMEs are bridging the gap between undergraduates and industry
-
ArticleStrength through diversity
Why people should be at the heart of a forward-thinking contract research organisation
-
NewsFirst building-integrated deployment shows perovskite solar’s growing maturity
Modules based on lightweight printed hybrid organic-inorganic films start to collect important real-world data
-
BusinessGSK and Pfizer joint venture creates new consumer healthcare giant
Enlarged GSK consumer health will have largest market share of any firm and be a leader in key countries